Quick Answer
CorMedix Inc. reported Operating Income Loss of $150.14 million for the year ending 2025.
- CorMedix Inc. showed an increase of +771.6% in Operating Income Loss from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), CorMedix Inc.'s Operating Income Loss has grown by 1,864.9%.
- Historical annual values: Fiscal year 2025: $150.14 million | Fiscal year 2024: -$22.36 million | Fiscal year 2023: -$48.96 million | Fiscal year 2022: -$30.62 million | Fiscal year 2021: -$29.44 million | Fiscal year 2020: -$27.22 million | Fiscal year 2019: -$21.01 million | Fiscal year 2018: -$26.86 million | Fiscal year 2017: -$32.92 million | Fiscal year 2016: -$24.76 million | Fiscal year 2015: -$16.65 million | Fiscal year 2014: -$8.90 million | Fiscal year 2013: -$4.92 million | Fiscal year 2012: -$3.00 million | Fiscal year 2011: -$7.25 million | Fiscal year 2010: -$8.51 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: